[Prostatic carcinoma. Zoledronic acid raises bone density].
Wirth
Manfred
M
Fröhner
Michael
M
Hausmann
Ralph
R
D015519:Bone Density / Q000187:drug effects*; D003720:Densitometry; D004164:Diphosphonates / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D004311:Double-Blind Method; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D015337:Multicenter Studies as Topic; D010024:Osteoporosis / Q000517:prevention & control; D010919:Placebos; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D013997:Time Factors; D000077211:Zoledronic Acid
D004164:Diphosphonates; D007093:Imidazoles; D010919:Placebos; D000077211:Zoledronic Acid